The global market for Cardiology Radiopharmaceuticals was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Cardiology Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cardiology Radiopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cardiology Radiopharmaceuticals in Therapeutic Use is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cardiology Radiopharmaceuticals include GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Jubilant Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cardiology Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiology Radiopharmaceuticals.

The Cardiology Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiology Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cardiology Radiopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cardiology Radiopharmaceuticals Market Report

Report Metric	Details
Report Name	Cardiology Radiopharmaceuticals Market
Segment by Type	Technetium-99 Fluorine-18 Gallium-67 Others
Segment by Application	Therapeutic Use Diagnostic Use
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Jubilant Life Sciences, Bracco
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiology Radiopharmaceuticals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cardiology Radiopharmaceuticals Market report?

Ans: The main players in the Cardiology Radiopharmaceuticals Market are GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Jubilant Life Sciences, Bracco

What are the Application segmentation covered in the Cardiology Radiopharmaceuticals Market report?

Ans: The Applications covered in the Cardiology Radiopharmaceuticals Market report are Therapeutic Use, Diagnostic Use

What are the Type segmentation covered in the Cardiology Radiopharmaceuticals Market report?

Ans: The Types covered in the Cardiology Radiopharmaceuticals Market report are Technetium-99, Fluorine-18, Gallium-67, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cardiology Radiopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Technetium-99

1.2.3 Fluorine-18

1.2.4 Gallium-67

1.2.5 Others

1.3 Market by Application

1.3.1 Global Cardiology Radiopharmaceuticals Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Therapeutic Use

1.3.3 Diagnostic Use

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cardiology Radiopharmaceuticals Market Perspective (2020-2031)

2.2 Global Cardiology Radiopharmaceuticals Growth Trends by Region

2.2.1 Global Cardiology Radiopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cardiology Radiopharmaceuticals Historic Market Size by Region (2020-2025)

2.2.3 Cardiology Radiopharmaceuticals Forecasted Market Size by Region (2026-2031)

2.3 Cardiology Radiopharmaceuticals Market Dynamics

2.3.1 Cardiology Radiopharmaceuticals Industry Trends

2.3.2 Cardiology Radiopharmaceuticals Market Drivers

2.3.3 Cardiology Radiopharmaceuticals Market Challenges

2.3.4 Cardiology Radiopharmaceuticals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cardiology Radiopharmaceuticals Players by Revenue

3.1.1 Global Top Cardiology Radiopharmaceuticals Players by Revenue (2020-2025)

3.1.2 Global Cardiology Radiopharmaceuticals Revenue Market Share by Players (2020-2025)

3.2 Global Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cardiology Radiopharmaceuticals Revenue

3.4 Global Cardiology Radiopharmaceuticals Market Concentration Ratio

3.4.1 Global Cardiology Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cardiology Radiopharmaceuticals Revenue in 2024

3.5 Global Key Players of Cardiology Radiopharmaceuticals Head office and Area Served

3.6 Global Key Players of Cardiology Radiopharmaceuticals, Product and Application

3.7 Global Key Players of Cardiology Radiopharmaceuticals, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiology Radiopharmaceuticals Breakdown Data by Type

4.1 Global Cardiology Radiopharmaceuticals Historic Market Size by Type (2020-2025)

4.2 Global Cardiology Radiopharmaceuticals Forecasted Market Size by Type (2026-2031)

5 Cardiology Radiopharmaceuticals Breakdown Data by Application

5.1 Global Cardiology Radiopharmaceuticals Historic Market Size by Application (2020-2025)

5.2 Global Cardiology Radiopharmaceuticals Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cardiology Radiopharmaceuticals Market Size (2020-2031)

6.2 North America Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025)

6.4 North America Cardiology Radiopharmaceuticals Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cardiology Radiopharmaceuticals Market Size (2020-2031)

7.2 Europe Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cardiology Radiopharmaceuticals Market Size by Country (2020-2025)

7.4 Europe Cardiology Radiopharmaceuticals Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cardiology Radiopharmaceuticals Market Size (2020-2031)

8.2 Asia-Pacific Cardiology Radiopharmaceuticals Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2020-2025)

8.4 Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cardiology Radiopharmaceuticals Market Size (2020-2031)

9.2 Latin America Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025)

9.4 Latin America Cardiology Radiopharmaceuticals Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cardiology Radiopharmaceuticals Market Size (2020-2031)

10.2 Middle East & Africa Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2020-2025)

10.4 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Details

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Cardiology Radiopharmaceuticals Introduction

11.1.4 GE Healthcare Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.1.5 GE Healthcare Recent Development

11.2 Cardinal Health

11.2.1 Cardinal Health Company Details

11.2.2 Cardinal Health Business Overview

11.2.3 Cardinal Health Cardiology Radiopharmaceuticals Introduction

11.2.4 Cardinal Health Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.2.5 Cardinal Health Recent Development

11.3 Curium Pharma

11.3.1 Curium Pharma Company Details

11.3.2 Curium Pharma Business Overview

11.3.3 Curium Pharma Cardiology Radiopharmaceuticals Introduction

11.3.4 Curium Pharma Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.3.5 Curium Pharma Recent Development

11.4 Lantheus Medical Imaging, Inc.

11.4.1 Lantheus Medical Imaging, Inc. Company Details

11.4.2 Lantheus Medical Imaging, Inc. Business Overview

11.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Introduction

11.4.4 Lantheus Medical Imaging, Inc. Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.4.5 Lantheus Medical Imaging, Inc. Recent Development

11.5 Eczacıbaşı Monrol Nuclear Products

11.5.1 Eczacıbaşı Monrol Nuclear Products Company Details

11.5.2 Eczacıbaşı Monrol Nuclear Products Business Overview

11.5.3 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Introduction

11.5.4 Eczacıbaşı Monrol Nuclear Products Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.5.5 Eczacıbaşı Monrol Nuclear Products Recent Development

11.6 Novartis International AG

11.6.1 Novartis International AG Company Details

11.6.2 Novartis International AG Business Overview

11.6.3 Novartis International AG Cardiology Radiopharmaceuticals Introduction

11.6.4 Novartis International AG Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.6.5 Novartis International AG Recent Development

11.7 Siemens

11.7.1 Siemens Company Details

11.7.2 Siemens Business Overview

11.7.3 Siemens Cardiology Radiopharmaceuticals Introduction

11.7.4 Siemens Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.7.5 Siemens Recent Development

11.8 China Isotope & Radiation

11.8.1 China Isotope & Radiation Company Details

11.8.2 China Isotope & Radiation Business Overview

11.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Introduction

11.8.4 China Isotope & Radiation Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.8.5 China Isotope & Radiation Recent Development

11.9 Yantai Dongcheng Pharmaceutical

11.9.1 Yantai Dongcheng Pharmaceutical Company Details

11.9.2 Yantai Dongcheng Pharmaceutical Business Overview

11.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Introduction

11.9.4 Yantai Dongcheng Pharmaceutical Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.9.5 Yantai Dongcheng Pharmaceutical Recent Development

11.10 Jubilant Life Sciences

11.10.1 Jubilant Life Sciences Company Details

11.10.2 Jubilant Life Sciences Business Overview

11.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Introduction

11.10.4 Jubilant Life Sciences Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.10.5 Jubilant Life Sciences Recent Development

11.11 Bracco

11.11.1 Bracco Company Details

11.11.2 Bracco Business Overview

11.11.3 Bracco Cardiology Radiopharmaceuticals Introduction

11.11.4 Bracco Revenue in Cardiology Radiopharmaceuticals Business (2020-2025)

11.11.5 Bracco Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cardinal Health

Curium Pharma

Lantheus Medical Imaging Inc

Eczacıbaşı Monrol Nuclear Products

Novartis International AG

China Isotope & Radiation

Jubilant Life Sciences

Bracco

GE Healthcare

Yantai Dongcheng Pharmaceutical

Siemens AG

List of Tables

Table 1. Global Cardiology Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Technetium-99

Table 3. Key Players of Fluorine-18

Table 4. Key Players of Gallium-67

Table 5. Key Players of Others

Table 6. Global Cardiology Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Cardiology Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Cardiology Radiopharmaceuticals Market Share by Region (2020-2025)

Table 10. Global Cardiology Radiopharmaceuticals Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Cardiology Radiopharmaceuticals Market Share by Region (2026-2031)

Table 12. Cardiology Radiopharmaceuticals Market Trends

Table 13. Cardiology Radiopharmaceuticals Market Drivers

Table 14. Cardiology Radiopharmaceuticals Market Challenges

Table 15. Cardiology Radiopharmaceuticals Market Restraints

Table 16. Global Cardiology Radiopharmaceuticals Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Cardiology Radiopharmaceuticals Market Share by Players (2020-2025)

Table 18. Global Top Cardiology Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Radiopharmaceuticals as of 2024)

Table 19. Ranking of Global Top Cardiology Radiopharmaceuticals Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Cardiology Radiopharmaceuticals Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Cardiology Radiopharmaceuticals, Headquarters and Area Served

Table 22. Global Key Players of Cardiology Radiopharmaceuticals, Product and Application

Table 23. Global Key Players of Cardiology Radiopharmaceuticals, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Cardiology Radiopharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Cardiology Radiopharmaceuticals Revenue Market Share by Type (2020-2025)

Table 27. Global Cardiology Radiopharmaceuticals Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Cardiology Radiopharmaceuticals Revenue Market Share by Type (2026-2031)

Table 29. Global Cardiology Radiopharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Cardiology Radiopharmaceuticals Revenue Market Share by Application (2020-2025)

Table 31. Global Cardiology Radiopharmaceuticals Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Cardiology Radiopharmaceuticals Revenue Market Share by Application (2026-2031)

Table 33. North America Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Cardiology Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Cardiology Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Cardiology Radiopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Cardiology Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 48. GE Healthcare Company Details

Table 49. GE Healthcare Business Overview

Table 50. GE Healthcare Cardiology Radiopharmaceuticals Product

Table 51. GE Healthcare Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 52. GE Healthcare Recent Development

Table 53. Cardinal Health Company Details

Table 54. Cardinal Health Business Overview

Table 55. Cardinal Health Cardiology Radiopharmaceuticals Product

Table 56. Cardinal Health Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 57. Cardinal Health Recent Development

Table 58. Curium Pharma Company Details

Table 59. Curium Pharma Business Overview

Table 60. Curium Pharma Cardiology Radiopharmaceuticals Product

Table 61. Curium Pharma Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 62. Curium Pharma Recent Development

Table 63. Lantheus Medical Imaging, Inc. Company Details

Table 64. Lantheus Medical Imaging, Inc. Business Overview

Table 65. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product

Table 66. Lantheus Medical Imaging, Inc. Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 67. Lantheus Medical Imaging, Inc. Recent Development

Table 68. Eczacıbaşı Monrol Nuclear Products Company Details

Table 69. Eczacıbaşı Monrol Nuclear Products Business Overview

Table 70. Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Product

Table 71. Eczacıbaşı Monrol Nuclear Products Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 72. Eczacıbaşı Monrol Nuclear Products Recent Development

Table 73. Novartis International AG Company Details

Table 74. Novartis International AG Business Overview

Table 75. Novartis International AG Cardiology Radiopharmaceuticals Product

Table 76. Novartis International AG Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 77. Novartis International AG Recent Development

Table 78. Siemens Company Details

Table 79. Siemens Business Overview

Table 80. Siemens Cardiology Radiopharmaceuticals Product

Table 81. Siemens Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 82. Siemens Recent Development

Table 83. China Isotope & Radiation Company Details

Table 84. China Isotope & Radiation Business Overview

Table 85. China Isotope & Radiation Cardiology Radiopharmaceuticals Product

Table 86. China Isotope & Radiation Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 87. China Isotope & Radiation Recent Development

Table 88. Yantai Dongcheng Pharmaceutical Company Details

Table 89. Yantai Dongcheng Pharmaceutical Business Overview

Table 90. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product

Table 91. Yantai Dongcheng Pharmaceutical Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 92. Yantai Dongcheng Pharmaceutical Recent Development

Table 93. Jubilant Life Sciences Company Details

Table 94. Jubilant Life Sciences Business Overview

Table 95. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product

Table 96. Jubilant Life Sciences Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 97. Jubilant Life Sciences Recent Development

Table 98. Bracco Company Details

Table 99. Bracco Business Overview

Table 100. Bracco Cardiology Radiopharmaceuticals Product

Table 101. Bracco Revenue in Cardiology Radiopharmaceuticals Business (2020-2025) & (US$ Million)

Table 102. Bracco Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Cardiology Radiopharmaceuticals Picture

Figure 2. Global Cardiology Radiopharmaceuticals Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cardiology Radiopharmaceuticals Market Share by Type: 2024 VS 2031

Figure 4. Technetium-99 Features

Figure 5. Fluorine-18 Features

Figure 6. Gallium-67 Features

Figure 7. Others Features

Figure 8. Global Cardiology Radiopharmaceuticals Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Cardiology Radiopharmaceuticals Market Share by Application: 2024 VS 2031

Figure 10. Therapeutic Use Case Studies

Figure 11. Diagnostic Use Case Studies

Figure 12. Cardiology Radiopharmaceuticals Report Years Considered

Figure 13. Global Cardiology Radiopharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Cardiology Radiopharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Cardiology Radiopharmaceuticals Market Share by Region: 2024 VS 2031

Figure 16. Global Cardiology Radiopharmaceuticals Market Share by Players in 2024

Figure 17. Global Top Cardiology Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Radiopharmaceuticals as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Cardiology Radiopharmaceuticals Revenue in 2024

Figure 19. North America Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Cardiology Radiopharmaceuticals Market Share by Country (2020-2031)

Figure 21. United States Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Cardiology Radiopharmaceuticals Market Share by Country (2020-2031)

Figure 25. Germany Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Cardiology Radiopharmaceuticals Market Share by Region (2020-2031)

Figure 33. China Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Cardiology Radiopharmaceuticals Market Share by Country (2020-2031)

Figure 41. Mexico Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Cardiology Radiopharmaceuticals Market Share by Country (2020-2031)

Figure 45. Turkey Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Cardiology Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. GE Healthcare Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 49. Cardinal Health Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 50. Curium Pharma Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 51. Lantheus Medical Imaging, Inc. Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 52. Eczacıbaşı Monrol Nuclear Products Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 53. Novartis International AG Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 54. Siemens Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 55. China Isotope & Radiation Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 56. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 57. Jubilant Life Sciences Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 58. Bracco Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22I19939

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38W19812

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39V16824

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions